Abstract: Hyperlipidemia causes systemic lipid disorder, which leads to hepatic steatosis and atherosclerosis. Thus, it is necessary to detect these syndromes early and precisely to improve prognosis. In the affected regions, abnormal formation and growth of lipid droplets is observed; therefore, lipid droplets may be a suitable target for the diagnosis of hyperlipidemia-related syndromes. In this study, we designed and synthesized 
Introduction
Hyperlipidemia or dyslipidemia is a chronic lipid disorder in which the lipid content in blood, such as cholesterol, increases abnormally [1] . This disease causes systemic lipid disorder, with manifestations such as fatty infiltration of the liver and lipid deposition in vessels, which leads to hepatic steatosis and atherosclerosis [2, 3] . Such hyperlipidemia-related syndromes are risk factors for severe diseases, such as liver dysfunction, liver cancer, and cerebral and myocardial infarction [4, 5] . Therefore, it is necessary to detect these syndromes early and precisely to improve prognosis.
Lipid droplets are an intracellular organelle where neutral lipids of cells are stored [6, 7] . In hepatic steatosis and atherosclerosis lesions, the abnormal formation and growth of lipid droplets is observed, and this is suspected to play a key role in the progression of these syndromes [8, 9] . Thus, abnormally enlarged lipid droplets may be a suitable target for the diagnosis of hyperlipidemia-related syndromes. To detect lipid droplets, several hydrophobic dyes, including fluorescent probes such as Nile red and boron dipyrromethene (BODIPY), have been reported for histological or microscopic visualization [10, 11] . Among these dyes, BODIPY493/503 demonstrated specific staining of lipid droplets and has been examined as an in vitro staining agent for the detection of lipid droplets in living cells [12] . For non-invasive in vivo imaging and clinical diagnosis, imaging modalities, such as positron emission tomography (PET), single photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI), are widely used [13] . Although several MRI probes based on BODIPY scaffolds have been developed for the diagnosis of vulnerable plaques [14, 15] , no PET or SPECT imaging probe targeting lipid droplets has been reported to exist.
Therefore, we aimed to develop novel nuclear medical imaging probes based on BODIPY scaffolds for the visualization of lipid droplet regions in hyperlipidemia-related syndrome. Technetium-99m ( 99m Tc) is one of the major radioisotopes for clinical SPECT imaging because the gamma rays emitted from 99m Tc with a photon energy of 141-keV are readily detectable by the SPECT scanner, and 99m Tc is easily produced using a molybdenum-99/technetium-99m generator. To label the BODIPY scaffold with 99m Tc, we selected two types of chelators: hydroxamamide (Ham) and N-methylated hydroxamamide (MHam).
Ham is a thiol-free chelating agent that produces the 99m Tc-complex with a high radiochemical yield under moderate reaction conditions [16, 17] . In addition, Ham forms the 99m Tc-complex with a metal-to-ligand ratio of 1:2, which makes it possible to easily produce 99m Tc-labeled compounds with a bivalent targeting scaffold [18, 19] . MHam is also a thiol-free chelating agent with similar properties to Ham, and the 99m Tc-complex with MHam exhibited higher stability in murine plasma than that with Ham [20, 21] . 
Results

Chemistry
The synthesis of Ham-BODIPY (2) and MHam-BODIPY (5) is outlined in Scheme 1. The BODIPY derivative 1 was synthesized thorugh the reaction of 4-formylbenzonitrile, 2,4-dimethylpyrrole, and boron trifluoride diethyl ether complex. A Ham group was introduced into 1 through a reaction with hydroxylamine, performed according to a previously reported method This produced Ham-BODIPY (2) from 4-formylbenzonitrile, with a yield of 9.7% [18] . MHam-BODIPY (5) was prepared in three steps from 2. Reaction of 2 with 1,1-carbonyldiimidazole provided compound 3 in DMSO. Then, 3 was methylated by iodomethane to give compound 4. Finally, 4 was decyclized by heating in an alkaline solution to MHam-BODIPY (5), with the overall yield of 1.0% from 4-formylbenzonitrile.
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Chemistry
The synthesis of Ham-BODIPY (2) and MHam-BODIPY (5) is outlined in Scheme 1. The BODIPY derivative 1 was synthesized thorugh the reaction of 4-formylbenzonitrile, 2,4-dimethylpyrrole, and boron trifluoride diethyl ether complex. A Ham group was introduced into 1 through a reaction with hydroxylamine, performed according to a previously reported method This produced Ham-BODIPY (2) from 4-formylbenzonitrile, with a yield of 9.7% [18] . MHam-BODIPY (5) was prepared in three steps from 2. Reaction of 2 with 1,1-carbonyldiimidazole provided compound 3 in DMSO. Then, 3 was methylated by iodomethane to give compound 4. Finally, 4 was decyclized by heating in an alkaline solution to MHam-BODIPY (5), with the overall yield of 1.0% from 4-formylbenzonitrile. 
Radiolabeling
The 99m Tc labeling reaction was performed by the complexation reaction using Ham-BODIPY (2) 
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Stability in Murine Plasma
The in vitro stability of [ 99m Tc]Tc-BOD was evaluated by incubation in murine plasma at 37 • C for 6 h. [ 99m Tc]Tc-BOD had a radiochemical purity of over 80% in murine plasma 6 h after incubation ( Figure 3 ). 
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In Vivo Biodistribution
The uptake of [ 99m Tc]Tc-BOD in each organ was expressed as the %ID/g, except for in the stomach, which was expressed as the %ID (Table 1) . [ 99m Tc]Tc-BOD exhibited gradual blood clearance (0.5 h: 4.98 ± 0.35, 6 h: 1.94 ± 0.12 %ID/g) and demonstrated relatively higher uptake in the liver (6 h: 15.22 ± 1.72 %ID/g) and stomach (6 h: 25.25 ± 5.30 %ID). 
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Discussion
In (Figure 3) . In normal mice, [ 99m Tc]Tc-BOD levels gradually decreased in the blood, which is suitable for SPECT imaging (Table 1) . However, [ 99m Tc]Tc-BOD also had relatively high uptake and retention in the stomach and liver. To visualize hepatic steatosis, [ 99m Tc]Tc-BOD (with its high uptake and retention in the liver) is not suitable. One strategy to solve this problem is to connect two Ham groups with a propylene linker, which was reported to reduce liver retention in a previous report [24] . Regarding the diagnosis of atherosclerosis, some previously reported probes also had high accumulation in the liver [25] . Therefore, [ 99m Tc]Tc-BOD holds potential for imaging lipid droplets in atherosclerotic lesions.
Several kinds of probes labeled with fluorine-18 and iodine-123/125 have been reported as radiolabeled probes with a BODIPY scaffold [26] [27] [28] . However, fluorine-18 is a cyclotron-produced isotope; this limits the production of fluorine-18-labeled probes because installation of a cyclotron system is expensive and requires a large facility. On the other hand, 99m Tc is easily produced using a molybdenum-99/technetium-99m generator without a large facility, and probes labeled with 99m Tc can be produced via a one-step reaction with 99m Tc. Some BODIPY-based compounds labeled with 99m Tc have been reported [11] . Compared with those compounds, the radiolabeling condition of [ 99m Tc]Tc-BOD is mild (only requiring incubation for 10 min at room temperature), which makes it more convenient for the acquisition of 99m Tc-labeled BODIPY. Thus, [ 99m Tc]Tc-BOD may be useful as a radiolabeled probe with a BODIPY scaffold.
A multimodal imaging technique combining nuclear medical imaging and fluorescence imaging has been developed. It is expected to integrate each advantage, such as a high spatial resolution in fluorescence imaging and a high signal permeability in nuclear medical imaging [29] . The BODIPY scaffold we used as a ligand targeting lipid droplets has suitable properties for fluorescence imaging (Supplementary Table S1 and Figure S2 ). Therefore, we tried to perform a microscopic fluorescence imaging study. In this study, we used Ham-BODIPY instead of [ 99m Tc]Tc-BOD because it is quite difficult to acquire enough 99m Tc-radiolabeled compound (i.e., approximately a femtomole level) for fluorescence imaging (Supplementary Figure S3) . (Figure 2A ). Therefore, we are now trying to optimize 99m Tc-labeled BODIPY probes for achieving more specific imaging of lipid droplets.
Materials and Methods
General
All reagents were obtained commercially and used without further purification unless otherwise indicated. [ 99m Tc]NaTcO 4 was purchased from Nihon Medi-Physics Co., Ltd. (Tokyo, Japan). W-Prep 2XY (Yamazen, Osaka, Japan) was used for silica gel column chromatography on a Hi Flash silica gel column (40 µm, 60 Å, Yamazen). 1 H-NMR and 13 C-NMR spectra were recorded on a JNM-ECS400 (JEOL, Tokyo, Japan) with tetramethylsilane as an internal standard. Coupling constants are reported in hertz. Multiplicity was defined as singlet (s), doublet (d), or multiplet (m). Mass spectra were obtained using a SHIMADZU LCMS-2020 (SHIMADZU, Kyoto, Japan). RP-HPLC was performed with a Shimadzu system (SHIMADZU, an LC-20AT pump with an SPD-20A UV detector, λ = 254 nm) with a Cosmosil C 18 column (Nacalai Tesque, Kyoto, Japan, 5C 18 -AR-II, diameter: 4.6 mm, length: 150 mm, particle size: 5 µm, pore size: 120 Å).
Chemistry
Synthesis of 1
Trifluoroacetic acid (TFA) (30 µL) and 2,4-dimethylpyrrole (1.00 g, 10.5 mmol) were added to a solution of 4-formylbenzonitrile (655 mg, 5 mmol) in dichloromethane (40 mL). The reaction mixture was stirred at room temperature for 6 h. To the reaction mixture, 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ) (1.14 g, 5 mmol), N,N-diisopropylethylamine (DIEPA) (10 mL), and boron trifluoride diethyl ether complex were added. The reaction mixture was then stirred at room temperature overnight. After the addition of water (80 mL), the mixture was extracted with dichloromethane (40 mL × 2). The organic layers were combined, dried over MgSO 4 , and filtered. Evaporation of the filtrate resulted in the formation of a residue, which was purified using silica gel chromatography (chloroform/hexane = 3/2) to give 313 mg of 1 (18% yield). 
Synthesis of 2 (Ham-BODIPY)
Hydroxylamine hydrochloride (188 mg, 2.7 mmol) and triethylamine (374 µL, 2.7 mmol) were added to a solution of 1 (313 mg, 0.9 mmol) in ethanol (20 mL). The reaction mixture was heated to reflux overnight. After the addition of water (60 mL), the mixture was extracted with chloroform (60 mL × 2). The organic layers were combined, dried over MgSO 4 , and filtered. Evaporation of the filtrate gave a residue, which was purified by silica gel chromatography (ethyl acetate/hexane = 9/1) to give 187 mg of 2 (Ham-BODIPY) (54% yield). 1 
Synthesis of 4
Iodomethane (86 µL, 1.38 mmol) and potassium carbonate (95 mg, 0.69 mmol) were added to a solution of 3 (94 mg, 0.23 mmol) in N,N-dimethylformamide (DMF) (20 mL). The reaction mixture was stirred at room temperature for 3 h. After the addition of water (50 mL), the mixture was extracted with chloroform (30 mL × 2). The organic layers were combined, dried over MgSO 4 , and filtered. Evaporation of the filtrate gave a residue, which was purified by silica gel chromatography (chloroform/methanol = 9/1) to give 57 mg of 4 (58% yield). 
Radiolabeling
To a solution of 2 (Ham-BODIPY) or 5 (MHam-BODIPY) (1 mg) in an acetic acid/ethanol mixture (1/4, 100 µL), 100 µL of [ 99m Tc]NaTcO 4 solution (37 MBq) and 30 µL of tin(II) tartrate hydrate solution (2 mg of tin(II) tartrate hydrate (7.5 µmol) dissolved in water (2.5 mL)) were added. The reaction mixture was incubated at room temperature for 10 min and purified by RP-HPLC on a Cosmosil 5C 18 -AR-II column (Nacalai Tesque, diameter: 4.6 mm, length: 150 mm, particle size: 5 µm, pore size: 120 Å) using the mobile phase (10 mM phosphate buffer (pH of 7.4)/acetonitrile = 60/40 (0 min) to 30/70 (30 min)) at a flow rate of 1.0 mL/min. To acquire [ 99m Tc]Tc-BOD, the two main peaks (retention time: around 17 to 18 min and around 20 to 21 min) were collected, combined, and then concentrated to remove acetonitrile. The mixture of those two fractions was used as [ 99m Tc]Tc-BOD in the subsequent examination. As for [ 99m Tc]Tc-MBOD, the main peak (retention time: around 20 to 21 min) was collected, then concentrated. The radiochemical yields of [ 99m Tc]Tc-BOD and [ 99m Tc]Tc-MBOD were calculated by dividing the radioactivity of the collected fraction (the mixture of the two peaks in the radiolabeling study of [ 99m Tc]Tc-BOD) by the radioactivity of the cludes measured before HPLC purification. The radiochemical purities were analyzed using RP-HPLC with the same method as the purification procedures.
Preparation of Foam Cells
Animal experiments were conducted in accordance with our institutional guidelines and approved by the Kyoto University Animal Care Committee. ddY mice were purchased from Japan SLC, Inc. (Shizuoka, Japan) and were housed with food and water supplied ad libitum under a 12-h light/12-h dark cycle. To serve as lipid droplet-rich model cells, we prepared mouse foam cells following a previously reported method [22] . In brief, 10% thioglycolate medium (10 mL) was injected intraperitoneally to ddY mice (females, 5 weeks old). After being housed for 4 days, the mice were sacrificed and the peritoneal cavity was washed using an injection of phosphate-buffered saline (PBS) (pH of 7.4) (Nacalai Tesque, Kyoto, Japan) to isolate macrophages. The macrophages were plated on 6-well plates (8 × 10 5 cells/well) and incubated in Dulbecco's modified Eagle's medium (DMEM) (4500 mg/L of Glucose; Nacalai Tesque) supplemented with 10% fetal bovine serum and 100 U/mL of penicillin and streptomycin at 37 • C in an atmosphere containing 5% CO 2 for 24 h. After incubation, the medium was removed and acetyl low density lipoprotein (LDL) (50 µg/mL) was added to the new medium (2 mL). Macrophages were incubated to form foam cells for 48 h. The formation of foam cells was confirmed by Oil red O staining. After removing the medium and washing twice with 1 mL of PBS (pH of 7.4), 2 mL of staining solution (Oil red O 1.8 mg/mL in 2-propanol/water = 3/2) was added to each well, and incubated at room temperature for 20 min. The staining solution was removed, and cells were washed twice with 1 mL of PBS (pH of 7.4). Bright field images were obtained using FSX-100 (Olympus, Tokyo, Japan).
In Vitro Cellular Uptake Study
[ 99m Tc]Tc-BOD (the mixtures of two isomers) or [ 99m Tc]Tc-MBOD (37 kBq, 2 mL in DMEM supplemented with 0.1% DMSO) was added to foam cells or non-foam cells cultured in 6-well plates (n = 6), and the plates were incubated at 37 • C in an atmosphere containing 5% CO 2 for 2 h. After incubation, each well was washed with 1 mL of PBS (pH of 7.4) and the cells were lysed with 1 M NaOH (0.2 mL × 2). The radioactivity of the cells was measured using a γ counter (Wallac 2470 Wizard; PerkinElmer, Waltham, MA, USA). The protein concentration was measured using a bicinchoninic acid protein assay kit (Thermo Fisher Scientific, Waltham, MA, USA).
Stability in Murine Plasma
[ 99m Tc]Tc-BOD (the mixtures of two isomers; 740 kBq) was added to freshly prepared murine plasma (200 µL) collected from ddY mice (male, 5 weeks old). After incubating the solution at 37 • C for 6 h, acetonitrile (200 µL) was added. Subsequently, the solution was centrifuged (4,000 g, 5 min) and the supernatant was analyzed using RP-HPLC. The analytical method of RP-HPLC was the same as that described in the radiolabeling section.
In Vivo Biodistribution
Male ddY mice (5 weeks old) were purchased from Japan SLC. Inc. (Shizuoka, Japan).
[ 99m Tc]Tc-BOD (the mixtures of two isomers) (480 kBq, 200 µL in saline supplemented with 0.1% DMSO) was injected into ddY mice via the tail vein. After injection, the mice were sacrificed at 0.5, 1, 3, or 6 h post-injection (n = 5, per time-point). The blood was collected, organs of interest (blood, spleen, pancreas, stomach, intestine, kidney, liver, heart, and lung) were dissected and weighed, and the radioactivity in each organ or tissue was measured using a γ counter (PerkinElmer). The results are expressed as a percentage of the injected dose per gram (%ID/g) for the selected organs, except the stomach whose result is expressed as a percentage of the injected dose (%ID).
Statistics
The student's t-test was used to assess the significance of differences. Differences at the 95% confidence level (p < 0.05) were considered significant.
Conclusions
